GSK sees falling vaccine sales take shine off earnings
The Independent

The drugs giant revealed vaccine sales fell 2% to £2.6 billion in the three months to September 30 as demand waned for its shingles and RSV jabs.
Summary from The Independent
Read the full story on The IndependentFollow











